发布求助
文献互助 智能选刊 最新文献

Academic Dermatology最新文献

筛选
英文 中文
How I Treat Alopecia in Patients with Cancer 我如何治疗癌症患者的脱发？
Academic Dermatology Pub Date : 2024-04-08 DOI: 10.18061/ad.v2i1.9745
Jordyn Puccio, Lucy Rose, Stephanie Adame, Brittany Dulmage
{"title":"How I Treat Alopecia in Patients with Cancer","authors":"Jordyn Puccio, Lucy Rose, Stephanie Adame, Brittany Dulmage","doi":"10.18061/ad.v2i1.9745","DOIUrl":"https://doi.org/10.18061/ad.v2i1.9745","url":null,"abstract":"For general dermatologists, the examination, diagnosis, and treatment of hair loss in patients with a history of cancer can be challenging. Previous and current chemotherapy, radiation therapy, and anti-cancer therapies need to be considered when developing a management strategy. Here we review strategies for reviewing patient medical histories, the incorporation trichoscopic examinations to aid with diagnosis, and special treatment considerations that do not increase risk of cancer reoccurrence. As novel anti-cancer therapeutics continue to be approved, it is imperative that dermatologists serve in support networks of patients experiencing dermatologic side effects. This article aims to aid dermatologists in the safe and effective treatment of hair-related side effects that negatively impact the survivorship of patients with cancer. ","PeriodicalId":376900,"journal":{"name":"Academic Dermatology","volume":"246 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140730359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Palisaded Neutrophilic and Granulomatous Dermatitis-Like Reaction Associated with Wilms Tumor 1 Protein-Derived Peptide Vaccine: A Case and Review of the Literature 与 Wilms Tumor 1 蛋白衍生多肽疫苗相关的嗜中性粒细胞和肉芽肿性皮炎样反应：一个病例和文献综述
Academic Dermatology Pub Date : 2024-04-08 DOI: 10.18061/ad.v2i1.9639
Lucy Rose, Michela Paradiso, Jose Plaza, David M. O'Malley, Brittany Dulmage
{"title":"Palisaded Neutrophilic and Granulomatous Dermatitis-Like Reaction Associated with Wilms Tumor 1 Protein-Derived Peptide Vaccine: A Case and Review of the Literature","authors":"Lucy Rose, Michela Paradiso, Jose Plaza, David M. O'Malley, Brittany Dulmage","doi":"10.18061/ad.v2i1.9639","DOIUrl":"https://doi.org/10.18061/ad.v2i1.9639","url":null,"abstract":"Palisaded neutrophilic and granulomatous dermatitis (PNGD) is an inflammatory cutaneous reaction that is associated with underlying autoimmune diseases. In rare cases, PNGD has been attributed to systemic medications. Here we report one case of a cutaneous injection-site reaction that occurred after intradermal administration of an experimental Wilms Tumor 1 (WT1) protein-derived peptide vaccine in a woman being treated for recurrent ovarian cancer. This is the first reported case of a PNGD-like reaction associated with immunotherapy injections. In this article, we discuss this case and summarize the literature related to the diagnosis and management of PNGD, as well as other injection site reactions related to immunotherapies and experimental vaccines.","PeriodicalId":376900,"journal":{"name":"Academic Dermatology","volume":"54 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140729389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hidradenitis Suppurativa-Induced Breast Abscess and Congenital Nipple Inversion Mimicking Inflammatory Breast Cancer with Review of the Literature 诱发乳腺脓肿和先天性乳头内陷的化脓性乳腺癌及文献综述
Academic Dermatology Pub Date : 2024-04-08 DOI: 10.18061/ad.v2i1.9475
Nathanael C. Jensen, Rachel M. Kirven, Abraham M. Korman
{"title":"Hidradenitis Suppurativa-Induced Breast Abscess and Congenital Nipple Inversion Mimicking Inflammatory Breast Cancer with Review of the Literature","authors":"Nathanael C. Jensen, Rachel M. Kirven, Abraham M. Korman","doi":"10.18061/ad.v2i1.9475","DOIUrl":"https://doi.org/10.18061/ad.v2i1.9475","url":null,"abstract":"Inflammatory breast cancer (IBC) is an aggressive, but rare, malignancy that may present cutaneously, so dermatologists may be some of the first providers to observe the initial clinical signs. A number of benign conditions may mimic the cutaneous and radiographic features of IBC. We present a case of a patient with hidradenitis suppurativa of the breast complicated by abscess formation with cutaneous findings mimicking IBC, including abrupt erythema, edema, nipple retraction, and peau d’orange changes. This case highlights dermatologic findings that should prompt an urgent evaluation for IBC, features that differentiate clinical mimickers from IBC, and potential pitfalls in diagnosing IBC if an improper or incomplete workup is pursued. We also present a review of the literature regarding mimickers of IBC.","PeriodicalId":376900,"journal":{"name":"Academic Dermatology","volume":"127 S193","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140731534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loading-Dose Dupilumab May Function as a Prophylactic Agent for Food-Induced Anaphylaxis: A Case and Review of the Literature 负荷剂量的杜匹单抗可作为食物诱发过敏性休克的预防药物：一个病例和文献综述
Academic Dermatology Pub Date : 2024-04-08 DOI: 10.18061/ad.v2i1.9666
Dean E. Watkins, Kaylee J Fredrickson, Patricia Malerich
{"title":"Loading-Dose Dupilumab May Function as a Prophylactic Agent for Food-Induced Anaphylaxis: A Case and Review of the Literature","authors":"Dean E. Watkins, Kaylee J Fredrickson, Patricia Malerich","doi":"10.18061/ad.v2i1.9666","DOIUrl":"https://doi.org/10.18061/ad.v2i1.9666","url":null,"abstract":"Recent advances in targeted therapy using monoclonal antibodies have revolutionized care in many fields, and dupilumab for the treatment of moderate-severe atopic dermatitis is no exception. While on a trial of loading dose dupilumab, a 25-year-old white male with a past medical history significant for anaphylaxis after ingesting peanuts and tree nuts did not experience anaphylaxis after accidentally consuming almonds. Similarly to anti-IgE, the large-scale inhibition of IL-4 and IL-13 signaling to various immune cells involved with type II hypersensitivity reactions using loading dose dupilumab may have played a role in preventing anaphylaxis in this patient. The role of loading dose dupilumab as a potential prophylactic agent against food-induced anaphylaxis could be explored cautiously as a novel way to reduce both morbidity and mortality in patients with these allergies.","PeriodicalId":376900,"journal":{"name":"Academic Dermatology","volume":"183 S486","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140731140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of Rash and Nonspecific Eruption Diagnoses Using ICD-9 and ICD-10 Codes 使用ICD-9和ICD-10代码验证皮疹和非特异性皮疹诊断
Academic Dermatology Pub Date : 2023-07-24 DOI: 10.18061/ad.v1i1.8860
M. Goldenberg, M. Amigo, S. Krishna, N. Milani-Nejad, J. Trinidad, B. Kaffenberger
{"title":"Validation of Rash and Nonspecific Eruption Diagnoses Using ICD-9 and ICD-10 Codes","authors":"M. Goldenberg, M. Amigo, S. Krishna, N. Milani-Nejad, J. Trinidad, B. Kaffenberger","doi":"10.18061/ad.v1i1.8860","DOIUrl":"https://doi.org/10.18061/ad.v1i1.8860","url":null,"abstract":"Despite being common cutaneous findings in the hospital setting, cutaneous drug eruptions have not been thoroughly validated for administrative claims data. The purpose of this study was to validate primary discharge diagnoses for the ICD code rash or other nonspecific eruptions by finding the positive predictive value (PPV) and to determine how often it was used to indicate an eruption that was eventually determined to be a drug eruption. Two dermatologists independently examined each of 39 hospital patient encounters to assess the validity of the ICD code used by stating whether the code used was appropriate or inappropriate, per table 1 criteria. Since in most patients, a drug eruption was suspected, the Naranjo Adverse Drug Reaction Probability Scale was utilized to externally validate our findings. Our results yielded a PPV for nonspecific rashes of 94.87% (83.11-98.58%) for appropriateness of use. The mean Naranjo score for appropriately versus inappropriately coded cases was 5.7 versus 2.5, respectively, with a mean difference of 3.17568 (0.18833-6.16302), (pooled P-value = 0.0378). Out of the cases analyzed, 29/39 or 74% were confirmed to be drug-related. Our high PPV supports the validity of non-specific eruptions found in national patient databases and the high Naranjo criteria suggest that often, these eruptions are drug related, yet not confirmed at the point of discharge.","PeriodicalId":376900,"journal":{"name":"Academic Dermatology","volume":"215 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124244333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peristomal Hidradenitis Suppurativa: A Case and Review of the Literature 化脓性表皮汗腺炎1例及文献复习
Academic Dermatology Pub Date : 2023-07-24 DOI: 10.18061/ad.v1i1.8816
Daniel Sosh, V. Varra, J. Kaffenberger
{"title":"Peristomal Hidradenitis Suppurativa: A Case and Review of the Literature","authors":"Daniel Sosh, V. Varra, J. Kaffenberger","doi":"10.18061/ad.v1i1.8816","DOIUrl":"https://doi.org/10.18061/ad.v1i1.8816","url":null,"abstract":"Hidradenitis suppurativa (HS) is a chronic, inflammatory condition of apocrine gland-bearing skin that typically presents as deep, inflamed lesions in the axillary, inguinal, perineal, and mammary regions. We present a rare case of a man in his 60s with a history of HS who presented with a peristomal sinus tract, as well as non-healing, draining wounds around his stoma site that responded well to adalimumab therapy. A compounded clobetasol ointment with poly(ethelyene oxide) polymers (POLYOXTM, Dupoont) was utilized to maintain stoma appliance adhesion, and his lesions effectively cleared with adalimumab.","PeriodicalId":376900,"journal":{"name":"Academic Dermatology","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124437099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study Protocol: Role of Intermittent Fasting on Disease Severity and Quality of Life in Psoriasis and Psoriatic Arthritis: A Single-Blind Parallel Group Randomized Control Trial 研究方案:间歇性禁食对银屑病和银屑病关节炎患者疾病严重程度和生活质量的作用:一项单盲平行组随机对照试验
Academic Dermatology Pub Date : 2023-07-24 DOI: 10.18061/ad.v1i1.9343
A. Gray, Lucy Rose, Dana Jolley, Bianka N Bubic, A. Korman, Brittany O. Dulmage, Jennifer A. Sopkovich, M. Bechtel, J. Kaffenberger, B. Kaffenberger
{"title":"Study Protocol: Role of Intermittent Fasting on Disease Severity and Quality of Life in Psoriasis and Psoriatic Arthritis: A Single-Blind Parallel Group Randomized Control Trial","authors":"A. Gray, Lucy Rose, Dana Jolley, Bianka N Bubic, A. Korman, Brittany O. Dulmage, Jennifer A. Sopkovich, M. Bechtel, J. Kaffenberger, B. Kaffenberger","doi":"10.18061/ad.v1i1.9343","DOIUrl":"https://doi.org/10.18061/ad.v1i1.9343","url":null,"abstract":"BACKGROUND Psoriasis and psoriatic arthritis (PsA) have a strong association with obesity and metabolic syndrome. Despite patient interest in non-pharmacologic methods to treat psoriasis and manage overall health, there is insufficient data available to guide dietary counseling. OBJECTIVE This study aims to identify the role of a popular anti-inflammatory diet known as intermittent fasting (IF) in psoriasis and psoriatic arthritis (PsA). METHODS A single-blind parallel group randomized control trial will be performed in 60 patients who have been diagnosed with psoriasis or PsA. Patients will be assigned 1:1 to either the IF group or control group. Patients assigned to the IF group will follow a 16:8 fasting IF method for the first 12 weeks, followed by the resumption of their routine diet. Patients assigned to the control group will follow their routine diet for 24 weeks. RESULTS A total of 24 patients have been enrolled in our study, with a final enrollment goal of 60 patients. The final visit is foreseen for July 2023. CONCLUSIONS This study aims to identify the role of a popular anti-inflammatory diet known as intermittent fasting (IF) in the management of psoriasis and PsA. Publishing this data will allow all dermatologists and the National Psoriasis Foundation to provide a consistent, evidence-based recommendation for IF as a potential non-pharmacologic intervention for patients with psoriasis and psoriatic arthritis (PsA).","PeriodicalId":376900,"journal":{"name":"Academic Dermatology","volume":"67 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124818529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Counseling for recreational drug use among patients with chronic inflammatory skin disease: A cross-sectional survey 慢性炎症性皮肤病患者娱乐性药物使用的咨询:一项横断面调查
Academic Dermatology Pub Date : 2023-07-24 DOI: 10.18061/ad.v1i1.8792
J. Nosewicz, Nathalie Ly, P. Macklis, B. Kaffenberger
{"title":"Counseling for recreational drug use among patients with chronic inflammatory skin disease: A cross-sectional survey","authors":"J. Nosewicz, Nathalie Ly, P. Macklis, B. Kaffenberger","doi":"10.18061/ad.v1i1.8792","DOIUrl":"https://doi.org/10.18061/ad.v1i1.8792","url":null,"abstract":"Multiple dermatologic diseases are associated with recreational drug use. Using a survey design, we approached patients with psoriasis, rosacea, and hidradenitis suppurativa to evaluate whether the patients had received counseling on drug use. In our sample, half of the patients with hidradenitis suppurativa were active smokers, and most had received smoking cessation counseling. Patients with psoriasis were also aware of an association with smoking yet not at the same rates as the hidradenitis suppurativa population. Future research is needed to corroborate this data in a larger sample, and to establish improved means to support lifestyle changes and interventions for dermatologic patients.","PeriodicalId":376900,"journal":{"name":"Academic Dermatology","volume":"74 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126887590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信